Eli Lilly

Biotech

Lilly buys inflammation biotech Ventyx for $1.2B

Ventyx achieved its goal of securing Big Pharma commitment to its pipeline, with Lilly swooping in to buy the inflammation biotech for $1.2 billion.

James Waldron Jan 8, 2026 7:01am

Three blocks displaying from left to right a person a handshake and another person

InduPro nabs 2nd Big Pharma deal with $950M Lilly pact

Jan 7, 2026 3:52pm

Yellow tape measure with a variety of weight loss medication on blue background

Lilly returns to Nimbus in $1.3B deal to create oral obesity med

Jan 6, 2026 10:05am

road closed construction sign

Neuro biotech Nido closes after 5 years

Jan 2, 2026 10:24am

Yellow tape measure with a variety of weight loss medication on blue background

Lilly's obesity pill maintains weight lost on injectable GLP-1s

Dec 18, 2025 8:20am

obesity overweight weight loss weigh

Lilly's obesity triple threat tops phase 3 efficacy forecasts

Dec 11, 2025 8:15am